VANDA Pharmaceuticals - Investor Relations - IR Home

Investor Relations

SEC Filings

SEC Filings

Filing date Form Description Filing Group View
8-K

Report of unscheduled material events or corporate event

Current Reports
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
8-A12B/A

Amendment to a previously filed 8-A12B

Registration Statements
View HTML
DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

Proxy Filings
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
ARS

An annual report to security holders

Annual Filings
View HTML
ARS/A

ARS/A

Annual Filings
View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
8-A12B

Registration of certain classes of securities 12(b) of the Securities Exchange Act

Registration Statements
View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML

Data provided by Kaleidoscope.

Copyright © 2005-2024 Vanda Pharmaceuticals Inc. |